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The Glasgow Outcome at Discharge Scale:
An Inpatient Assessment of Disability after Brain Injury
Thomas M. McMillan,1 Christopher J. Weir,2 Alaister Ireland,3 and Elaine Stewart1
Abstract
This study assesses the validity and reliability of the Glasgow Outcome at Discharge Scale (GODS), which is a tool that is
designed to assess disability after brain injury in an inpatient setting. It is derived from the Glasgow Outcome Scale-
Extended (GOS-E), which assesses disability in the community after brain injury. Inter-rater reliability on the GODS is
high (quadratic-weighted kappa 0.982; 95% confidence interval [CI] 0.968, 0.996) as is concurrent validity with the
Disability Rating Scale (DRS) (Spearman correlation - 0.728; 95% CI - 0.819, - 0.601). The GODS is significantly
associated with physical and fatigue subscales of the short form (SF)-36 in hospital. In terms of predictive validity the
GODS is highly associated with the GOS-E after discharge (Spearman correlation 0.512; 95% CI 0.281, 0.687), with the
DRS, and with physical, fatigue, and social subscales of the SF-36. The GODS is recommended as an assessment tool for
disability after brain injury pre-discharge and can be used in conjunction with the GOS-E to monitor disability between
hospital and the community.
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Introduction
Brain-injured patients are cared for in a range of acutehospital wards, including orthopedic and general medicine,
where there is limited training and expertise in the sequelae of
brain injury. Most are discharged when physically able, without
assessment for persisting cognitive and emotional problems and
without assessment of rehabilitation or care needs or appropriate
referral.1,2 An assessment of disability in inpatient settings with a
simple and robust measure usable by non-specialist ward staff
would be useful in addressing these issues in several ways. For
example, such a measure might inform about disability when
decisions about the appropriateness of hospital transfer or dis-
charge are being considered. If categorizing disability during
prolonged hospital stays, it may indicate the need for specialist
assessment or referral to allied health professionals or clinical
neuropsychology or the need for a social work assessment before
discharge.
An association with function in the community would also make
it potentially useful as a pre-discharge predictor of later needs and,
hence, of use in discharge decision making, discharge planning
(including identifying a need for rehabilitation and care), and in
clinical audit. If coherently linked to an outpatient measure, an
inpatient measure might also be used to assess change in disability
across inpatient and community settings, including before and after
interventions. In research in acute care, it may form a baseline to
monitor ‘‘natural’’ outcome or outcome in response to treatment or
act as a ‘‘surrogate’’ early end-point that may, to an extent, com-
pensate for loss to follow-up.
The Glasgow Outcome Scale (GOS)3 is the most widely cited
assessment of outcome in the community after brain injury.4 The
GOS and its more sensitive extended form, the Glasgow Outcome
Scale-Extended (GOS-E)5,6 can be administered in busy clinical
settings by professionals from a range of backgrounds and does not
require training in neurology or neuropsychology. Both the GOS
and GOS-E are simple and quick to administer and are valid and
reliable when used in face to face interview, telephone interview, or
in amended form by postal return.6–10 The GOS is not valid in a
hospital setting, however, because a key criterion is restitution of
independence in society. Despite this, the GOS continues to be used
inappropriately in studies on hospitalized patients, emphasizing a
demand for an inpatient version.
Although a variety of scales have been developed to assess the
recovery and progress of inpatients with brain injury, attention has
largely focused on neurorehabilitation where the scales commonly
require training and are time consuming and less reliable than the
GOS.11,12 Few scales assess outcome across acute hospital and
community settings. The Disability Rating Scale (DRS) was de-
veloped to assess change during rehabilitation, but it has been re-
ported to be less sensitive than the GOS-E.13
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Hence, we have devised an inpatient version of the GOS-E—the
Glasgow Outcome at Discharge Scale (GODS)—to enable as-
sessment of disability after brain injury in an inpatient setting in-
cluding by general ward staff who are instructed in its use, but need
not be specialists in brain injury or rehabilitation. We report data on
validity and reliability.
Methods
Adult patients admitted to a Glasgow hospital for 24 h or more
after a brain injury were assessed near to discharge.Written consent
was obtained near to discharge to home when the hospital had
decided that the patient had mental capacity and was fit for dis-
charge. Ethics approval was obtained from the West of Scotland
Research Ethics Committee. To be included, potential participants
had to be age 16 years or more, to be fluent in English, and to have
been admitted to hospital overnight or longer because of a brain
injury. The pre-discharge assessment involved a short interview by
the research worker with nursing staff that knew the patient well
(and who would have a key role in completing the GODS should it
be adopted in clinical practice) in addition to interviewing the pa-
tient. At the pre-discharge assessment, in addition to the GODS and
the DRS,14 indicators of severity of brain injury were obtained.
These were duration of loss of consciousness and minimum Glas-
gow Coma Scale score during hospital admission.
The follow-up appointment was arranged at the time of the in-
patient assessment and planned within a few weeks of discharge.
The post-discharge assessment involved the patient and a signifi-
cant other (as is the norm for the GOS-E). The post-discharge
assessment included the GOS-E and DRS as measures of general
outcome. As an independent, subjective indicator of health out-
come, the 36-item Short Form Health Survey (SF-36)15 was ad-
ministered pre- and post-discharge. Concurrent and convergent
validity was assessed by comparing GODS scores with the DRS
and SF-36, respectively, in the inpatient setting. Predictive validity
was assessed by comparing the GODS with outpatient adminis-
tration of the GOS-E, the DRS, and the SF-36. A checklist re-
garding rehabilitation provision and attendance was administered
at the community follow-up assessment, because this could be a
confounding factor that affects outcome between discharge and
follow-up.
Given that brain injury is often associated with excess habitual
alcohol drinking and that an early return to drinking might have a
rapid and negative effect on outcome, the Alcohol Use Disorders
IdentificationTest (AUDIT)16 was administered at post-discharge
assessment. Inter-rater reliability was assessed using the GODS on
two separate occasions by two members of our research team
within a 24-h period after the patient was deemed fit for discharge.
Sample size and statistics
The GOS-E has inter-rater reliability between telephone inter-
view and in-person assessment of 0.84 (95% confidence interval
[CI] 0.58 to 1.00) as measured by the quadratic-weighted kappa
statistic.10 Cohen17 proved that for a general tabulation of the results
from two raters on a scale with several categories, the quadratic-
weighted kappa is exactly equivalent to the standard product-
moment correlation coefficient if the marginal distributions are
identical. Table 2 in the article by Pettigrew and associates10 shows
that in the context of the GOS-E, the marginal distributions from
each assessment are indeed very similar. We therefore base the
sample size calculation for quadratic-weighted kappa on that for the
product-moment correlation coefficient r. Algina and Olejnik18
provide tables for the product-moment correlation coefficient in
terms of the sample size needed to achieve a given width of CI for a
range of possible true values of r. Hence, we estimated that about 60
patients were needed for the reliability study and, from previous
studies, approximately 80 to assess validity.6–10
Inter-rater reliability on the GODS was assessed using the
quadratic-weighted kappa and 95% CI. Concurrent and conver-
gent validity (association between GODS and each of inpatient
DRS and SF-36, respectively) was quantified by the Spearman
rank correlation coefficient and 95% CI. Predictive validity (as-
sociation between GODS pre-discharge and GOS-E shortly after
hospital discharge) was measured using the Spearman rank cor-
relation coefficient and 95% CI. Predictive validity for moderate
or severe disability on GOS-E was assessed using sensitivity,
specificity, positive predictive value and negative predictive va-
lue with exact binomial CIs. The characteristics of those who
were and were not successfully followed up were compared for
categorical variables using the chi-square test and for continuous
variables by two sample t test or Wilcoxon-Mann-Whitney test as
appropriate.
Results
Pilot study
Ten health professionals (medicine; surgery; nursing; occupa-
tional therapy) commented on the construct validity of the GODS.
All had some clinical experience with brain injury, and eight did not
specialize in brain injury (to reflect admission in Scotland—usually
to a medical or a surgical ward and not to a specialist brain injury
team). The overall view was that the GODS is a useful tool that
seems straightforward to use and that would predict outcome in the
community. On the basis of comments, minor changes to the GODS
were made. Where possible, the wording of the GODS was kept the
same as or consistent with that of the GOS-E. The GODS is available
free to download (http://www.gla.ac.uk/researchinstitutes/healthwell
being/staff/tommcmillan).
Characteristics of the sample
Recruitment approximated to the estimated sample size, with 77
persons being recruited to the study and inter-rater reliability as-
sessed in 56. Follow-up after discharge was achieved in 53/77
(69%). Those followed up (F) and lost to follow-up (NF) did not
differ significantly in terms of age (two sample t test, p = 0.66; mean
50 (F) versus mean 52 (NF) 95% CI for difference - 8.0, 12.6),
male sex (64% F, 71% NF: p= 0.57, odds ratio 0.74, 95% CI 0.26–
2.09), or GODS (F: median 5; NF: median 4.5; Wilcoxon Mann
Whitney test = 0.20) or DRS scores (F: median 3; NF: median 3;
Wilcoxon Mann Whitney test 0.48).
Initial characteristics are presented in Table 1. On the GODS,
41.6% had severe disability, 29.9% moderate disability, and 28.6%
good recovery. At follow-up on the GOSE, 30.2% were severely
disabled (SD), 39.6% moderately disabled (MD), 30.2% had good
recovery (GR), with data missing in 31.2% who were not available
at follow-up (Table 2). GODS scores were not associated with age
(Spearman r - 0.069; 95% CI - 0.288, 0.158), p= 0.55). There was
a slight trend toward greater disability in females (median upper
SD) than males (median upper MD; Wilcoxon Mann Whitney,
p= 0.059).
Inter-rater reliability
The quadratic weighted kappa on the GODS between two ob-
servers (a research nurse and a research psychologist) was 0.982
(95%CI: 0.968, 0.996; n = 56). The full range of GODS scores from
lower SD to upper GR were represented, with perfect agreement in
22 SD, 11 MD, and 17 GR cases and disagreement in 3 SD and in 3
MD cases, all by one point.
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Validity
In terms of concurrent validity, the GODS was highly correlated
with the in-hospital DRS, and in terms of convergent validity, the
GODS significantly correlated with the in-hospital SF-36 factors
physical function, role limitations because of physical health, en-
ergy/fatigue, and had a borderline significant association with so-
cial functioning (Table 2).
In terms of predictive validity, a moderately strong and highly
significant relationship was found between GODS scores in hos-
pital and GOSE scores at follow-up (Spearman r = 0.512,
p < 0.0001; CI 0.281, 0.687). If intending to operate a simple
clinical decision making rule using the GODS, (such as those with
MD or SD at discharge need intervention or assessment for inter-
vention and those with good recovery need a brief follow-up such
as by telephone or letter),19,20 the GODS correctly predicts dis-
ability (GOS-E) at follow-up with a sensitivity of 89% (95% CI,
75% to 97%), specificity of 75% (95% CI, 48% to 93%), with a
positive predictive value of 89% (95% CI, 75% to 97%) and neg-
ative predictive value of 75% (95% CI, 48% to 93%).
It did not predict disability at follow-up in four (7%), and four
others (7%) had false positives results (i.e., predicts disability but
had good recovery). Of the four patients who deteriorated from GR
to disabled (Table 3), one had a heart attack after discharge, severe
anxiety in relation to symptom persistence developed in one, and
two deteriorated and needed further CT brain investigation. In
terms of the four who improved from disabled to GR, the context
was resolution of symptoms of vomiting in one case and resolution
of impaired balance in three.
The GODS correlated highly with the post-discharge DRS and
more modestly with the SF-36 factors physical function and role
limitations because of physical health and social functioning (Table 4).
Outcome at Follow-up
The earliest follow-up was 12 days after discharge, and the
median time to follow-up was 22 days (interquartile range 19 days).
Brain injury was subjectively viewed by participants as the most
important factor affecting outcome at follow-up in 43/53 (81%).
The remaining 10 participants (19%) thought that other injury or
illness best explained their outcome. Scores on the AUDITwere not
associated with differences in scores between GODS and GOS-E
Table 2. Spearman Correlations between
the Glasgow Outcome at Discharge Scale and Measures
of Disability and Function in Hospital
Correlation; p value 95% CI
Disability Rating Scale - 0.728; p< 0.0001 - 0.819, - 0.601
SF-36 Physical function 0.459; p< 0.0001 0.258, 0.623
SF-36 Role limitations
physical
0.227; p= 0.016 0.051, 0.475
SF-36 Emotional
well-being
0.003; p= 0.98 - 0.227, 0.233
SF-36 Role limitations
emotional
0.177; p= 0.13 - 0.053, 0.390
SF-36 Energy/fatigue 0.230; p= 0.049 - 0.001, 0.437
SF-36 Social function 0.220; p= 0.058; - 0.009, 0.427
SF-36 Pain 0.116; p= 0.32 - 0.116, 0.335
SF-36 General health - 0.028; p= 0.81 - 0.257, 0.203
CI, confidence interval; SF, short form.
Table 1. Personal and Injury Characteristics
and Glasgow Outcome
at Discharge Scale Outcome (n = 77)
Characteristic
Age in years (mean (SD); range) 50.59 (21.01); 17–94
Sex (male/female) 51 (66.2%)/26 (33.8%)
Disability before admission 3 (3.9%)
GCS in hospital
Mild (13–15) 59 (76.6%)
Moderate (9–12) 4 (5.2%)
Severe (3–8) 10 (13.0%)
Unknown 4 (5.2%)
Loss of consciousness:
None/minimal
31 (40.3%)
1 to 30min 27 (35.1%)
> 30mins 14 (18.2%)
Unknown 5 (6.5%)
Glasgow Outcome at Discharge Scale
Upper good recovery 8 (10.4%)
Lower good recovery 14 (18.2%)
Upper moderate disability 13 (16.9%)
Lower moderate disability 10 (13.0%)
Upper severe disability 19 (24.7%)
Lower severe disability 13 (16.9%)
SD, standard deviation; GCS, Glasgow Coma Scale.
Table 3. Glasgow Outcome at Discharge Scale
and Glasgow Outcome Scale-Extended Scores (n= 53)
GOS-E
Lower SD
Upper
SD
Lower
MD
Upper
MD
Lower
GR
Upper
GR
GODS Lower SD 2 2 1 1
Upper SD 1 6 4 1 1 1
Lower MD 5 2
Upper MD 1 1 3 4 1
Lower GR 1 1 1 5 2
Upper GR 1 5
GOS-E, Glasgow Outcome Scale-Extended; GODS, Glasgow Outcome
at Discharge Scale; SD, severe disability; MD, moderate disability; GR,
good recovery.
Table 4. Spearman Correlations between
the Glasgow Outcome at Discharge Scale
and Measures of Disability Post-Discharge
Correlation; p value 95% CI
Disability Rating Scale - 0.476; p= 0.00025 - 0.663, - 0.234
SF-36 Physical function 0.426; p= 0.0015 0.170, 0.628
SF-36 Role limitations
physical
0.400; p= 0.0031 0.139, 0.608
SF-36 Emotional
well-being
0.002; p= 0.99 - 0.274, 0.277
SF-36 Role limitations
emotional
0.094; p= 0.51 - 0.187, 0.360
SF-36 Energy/fatigue 0.150; p= 0.29 - 0.131, 0.409
SF-36 Social function 0.336; p= 0.014 0.067, 0.560
SF-36 Pain 0.202; p= 0.32 - 0.078, 0.452
SF-36 General health 0.035; p= 0.80 - 0.243, 0.308
SF, short form; CI, confidence interval.
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(Spearman r - 0.049; 95% CI - 0.317, 0.227, p= 0.73) or GOS- E
scores at follow-up (Spearman r 0.001; 95% CI - 0.272, 0.274,
p = 0.99). At follow-up, 13 (25%) had seen their general practi-
tioner about the brain injury. Eleven had been admitted to specialist
inpatient neurorehabilitation pre-discharge (9/36 of those who were
disabled at discharge) and an additional four to outpatient therapy
services post-discharge. In those who were disabled on the GODS,
there was no significant difference in change scores (GODS minus
GOS-E) between those who received specialist rehabilitation and
those who did not (Mann Whitney test, p= 0.97).
Discussion
We were able, with input from expert colleagues and from po-
tential inexpert users to adapt the GOS-E for use with brain injury
patients before discharge from hospital care. The results of studies
reported here demonstrate themerits of high validity and high inter-
rater reliability. These initial findings suggest that the GODS will
be useful in research or clinical contexts. On the basis of the pilot
study with ward staff and from our other studies involving acute
wards, our perception is that the GODS is more likely to achieve
routine use by ward staff than is, for example, a measure of post-
traumatic amnesia that might involve assessment of attention and
memory. There are three reasons for this. First, in our experience,
ward staff are not keen to perform cognitive assessment routinely,
especially if test equipment has to be used. Second, the GODS is
relevant to all persons admitted with a brain injury and not just
those where post-traumatic amnesia is an issue. Finally, the GODS
focuses on disability rather than impairment and, given this, the
GODS has direct, practical implications that may reveal potential
problems to ward staff and help in decision making and plans for
discharge.
The study has several strengths. The patients were sampled from
across the spectrum of severities of brain injury admitted to hos-
pital; within this, the large proportion with a mild brain injury is
consistent with the demographics of hospitalized brain injury,1 and
with the potential use of the GODS in the non-specialist wards
where these patients tend to be admitted. Similarly, patients cov-
ered the range of categories in the GODS from upper GR to lower
SD. The loss of patients to follow-up limited the analysis of rela-
tionships between the GODS and the GOS-E, but is typical of these
patients.2 The follow-up rate of almost 70% is high for studies of
this kind and, of note, is the absence of any systematic loss at
follow-up in relation to age, sex, GODS, or DRS scores.
The GODS has a very high inter-rater reliability, using raters from
different professional backgrounds, and this attests to its potential in
non-specialist settings. TheGODS has a high concurrent validity with
the DRS, which is a well-established measure of disability. Con-
vergent validitywas demonstratedwith the SF-36 in terms of physical
but not emotional concerns during hospital stay. This may reflect a
focus on physical complaints and fatigue early after injury in a gen-
eral hospital setting. This may be because of the evident nature of the
physical symptoms in hospital whereas emotional problems or de-
mands associated with cognitive functions such as memory or
problem solving or associated with daily function are limited for the
patient and can be less obvious in a ward environment, which by its
nature is essentially supportive and non-challenging.
The GODS predicts outcome on the GOS-E and the DRS soon
after discharge. Predictive accuracy on the GOS-E is particularly
high if considering outcome in terms of GOS-E categories of dis-
ability (SD or MD) or GR. These categories are potentially of
practical use in relation to discharge planning,18 and in the simple
and practical terms of deciding about the need for brief follow-up
(GR) or for planning a more detailed assessment of neurorehabil-
itation (disabled). The degree of association between the GODS
and the GOS-E was reduced when there was early recovery in the
community; for example, from complaints that were largely
physical such as impaired balance and also by deterioration in a few
patients.
Nevertheless, the sensitivity of the GODS in terms of simple
clinical decision making was high and the specificity adequate.
Outcome prediction was not confounded by alcohol drinking on
return to the community in this sample. As in hospital, the asso-
ciations between the GODS and the SF-36 at early follow-up in the
community were dominated by a focus on physical symptoms, and
the trend toward a significant association with social function in
hospital became significant in the community. Specialist provision
of support or rehabilitation was infrequent in the sample, and there
was no indication that this was a confounding factor.
The study is limited by use of research staff rather than ward staff
in assessing the reliability and validity of the GODS and by the
limited data pertaining to the clinical utility of the GODS in fa-
cilitating decision making with regard to planning of discharge or
hospital transfer to rehabilitation. In terms of further work, the
validation of the GODS would benefit from the development of
training materials with online accessibility and validation of its use
by ward staff trained using these materials. Further development of
the clinical use of the GODS as a guide to discharge planning and
independent replication of this validity study are also important.
Future work might consider the relationships between GODS score
and later outcome after discharge. If ability of the GODS to predict
outcome at later time points is of interest (e.g., 6 or 12 months),
additional factors that might influence outcome should be taken
into account, such as provision of rehabilitation, social support, and
any further health difficulties.
Conclusion
We conclude that the GODS is a valid and reliable tool for use in
acute hospital wards to assesses disability after brin injury. It has a
good association with the community version, the GOS-E, and has
potential uses to audit early outcome in patients in hospital, to
enhance decisions about discharge planning, to evaluate the out-
come of interventions in inpatient and community settings, and to
support longitudinal assessment of change in disability across in-
patient and community settings.
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